Infinity Pharmaceuti (NQ: INFI )

3.150 USD +0.160 (+5.35%)

Streaming Delayed Price Updated: 2:09 PM EDT, May 7, 2021 Add to My Watchlist

Price and Volume

Volume	463,291
Open	3.020
Bid (Size)	3.150 (8)
Ask (Size)	3.160 (16)
Prev. Close	2.990
Today's Range	2.960 - 3.180
52wk Range	0.7800 - 5.980
Shares Outstanding	88,639,741
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Infinity Announces the Date of Its First Quarter 2021 Financial Results Conference Call and Webcast

May 06, 2021

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI), a clinical-stage biotechnology company developing eganelisib, a potentially first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic...

Infinity to Present at New York Academy of Sciences’ Frontiers in Cancer Immunotherapy 2021

May 05, 2021

Performance

YTD	+55.17%	+55.17%
1 Month	-1.25%	-1.25%
3 Month	-14.63%	-14.63%
6 Month	+186.36%	+186.36%
1 Year	+178.76%	+178.76%

More News

Infinity to Present at the 7th Annual Truist Securities Life Sciences Summit

April 27, 2021

12 Health Care Stocks Moving In Tuesday's After-Market Session

May 04, 2021

Infinity Pharmaceuticals Reports Full Year 2020 Financial Results and Provides Update on Eganelisib Development

March 16, 2021

First Week of INFI June 18th Options Trading

April 16, 2021

Infinity to Present at the Oppenheimer & Co. Annual Healthcare Conference

March 10, 2021

Thinking about buying stock in electroCore, Hall of Fame Resort & Entertainment, Dolphin Entertainment, Alithya Group, or Infinity Pharmaceuticals?

April 08, 2021

Infinity Announces the Date of Its Fourth Quarter and Full Year 2020 Financial Results Conference Call and Webcast

March 09, 2021

Thinking about buying stock in SuperCom, Clovis Oncology, Mogo Inc, Evolus, or Infinity Pharmaceuticals?

March 19, 2021

12 Health Care Stocks Moving In Thursday's Intraday Session

March 18, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.